For patients aged 6 years and older with POMC deficiency, PCSK1 deficiency, LEPR deficiency, or BBS, MC4R agonists are approved which could be considered when available and reimbursed. Here, BBS2 is linked to hyperinsulinemic hypoglycemia, familial, 4.